
Telmik-Trio 50 Tablet ER
Marketer
Sepik Life Sciences
Salt Composition
Cilnidipine (10mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)
Overview Telmik-Trio 50 Tablet ER
Telmik-Trio 50 ER tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. This medication can be ingested with food at any time of day, ideally consistently at the same hour. Continue treatment as directed by your physician; discontinuation, even with symptom absence, may worsen your condition. Lifestyle modifications, including regular exercise, weight management, and a balanced diet, complement this therapy. Adhere strictly to your doctor's instructions. Potential side effects include nausea, altered taste perception, pharyngitis, backache, and edema in the ankles. Elevate your legs to alleviate ankle swelling. Avoid potassium-rich foods and supplements. Regular monitoring of blood pressure, renal function, glucose levels, and electrolytes may be necessary. Inform your doctor of any pre-existing liver or kidney ailments before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Fully disclose all current medications, especially those for hypertension or cardiac issues.
Uses of Telmik-Trio 50 Tablet ER
Elevated blood pressure
Major Benefits of Telmik-Trio 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Telmik-Trio 50 Tablet ER whole; do not chew, crush, or break it. Administer this medicine with a meal.
Common Side effects of Telmik-Trio 50 Tablet ER:
- Nausea
- Taste change
- Diarrhea
- Headache
- Dizziness
- Weakness
- Ankle swelling
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Edema (swelling)
- Slow heart rate
- Cold extremities
- Decreased blood pressure
- Throat infection
How to use Telmik-Trio 50 Tablet ER:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Telmik-Trio 50 ER Tablet with a meal.
How Telmik-Trio 50 Tablet ER works:
Extended-release Telmisartan/Amlodipine/Hydrochlorothiazide 50mg tablets contain a triple-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmik-Trio 50 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Telmisartan/Hydrochlorothiazide 50mg tablets (Telmik-Trio 50 equivalent) pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Telmik-Trio 50 Extended-Release tablets with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Extended-release Telmik-Trio 50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Telmik-Trio 50 Tablet ER's efficacy and safety in individuals with impaired renal function. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Telmik-Trio 50 ER tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Telmik-Trio 50 ER tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Telmik-Trio 50 Tablet ER :
Should you forget a Telmik-Trio 50 Tablet ER dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmik-Trio 50 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
